GLP-1 medications are reshaping the weight management landscape — and beginning to take a bite out of bariatric surgery volumes in hospitals. Between 2022 and 2023, bariatric surgery rates fell 25.6% ...

Skinny jab? Try skinny juice. For centuries, it’s been enjoyed by people in South America — and it’s long been linked to weight loss.

But researchers are enamored with the pointy-face shrew for another one of its natural talents: It vomits. That makes the ...

CEO Wendy Davidson said the Sleepytime Tea maker needed to first stabilize its business and boost innovation before it could tap into movements such as GLP-1 use.

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching emerging channels and artificial ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

On March 27, 2025, Vivani announced an $8.25 million equity financing which secures solid financial position into the second ...

Bill Gates was asked to share 'one problem money cannot fix', when he reacted to PM Modi's take on combating obesity with yoga, among other 'behaviour changes'.

Key Takeaways More people with type 1 diabetes are severely obese and using GLP-1 drugs for weight lossExperts are concerned ...

There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...